Intraocular Lymphoma: When to Suspect a Sinister Cause of Ocular Haemorrhage
Catarina Pestana Santos1, Rosa Alves1, Bruno Sousa1, Ana Cláudia Vieira2, Tiago Judas1
1 Internal Medicine Department, Hospital Garcia de Orta, Almada, Lisbon, Portugal
2 Pneumology Department, Hospital Garcia de Orta, Almada, Lisbon, Portugal
Doi: 10.12890/2022_003622 - European Journal of Case Reports in Internal Medicine - © EFIM 2022
Received: 05/10/2022
Accepted: 30/11/2022
Published: 28/12/2022

How to cite this article: Pestana Santos C, Alves R; Sousa B, Vieira AC, Judas T. Intraocular lymphoma: when to suspect a sinister cause of ocular haemorrage. EJCRIM 2022;9 doi:10.12890/2022_003622.

Conflicts of Interests: The authors declare there are no competing interests.
Patient consent: The patient agreed to the collection of data and publication of this report.
This article is licensed under a Commons Attribution Non-Commercial 4.0 License

ABSTRACT

Intraocular lymphoma (IOL) is a rare and life-threatening condition whose aetiology is unclear. Blurred vision, reduced vision, and floaters are common initial symptoms. Posterior vitreous detachment and haemorrhage rarely occur.
The authors present the case of a 79-year-old man who initially presented with a 3-month history of fever, night sweats, significant weight loss, bilateral peri-orbital haematoma, red eyes and retro-orbital headache. Physical examination revealed fever, bilateral peri-orbital haematoma, subconjunctival haemorrhage and palpable cervical lymphadenopathy. CT scans detected conical intra-orbital lesions, cervical adenomegalies, expansive lesions in the adrenal glands, and thrombosis of the splenomesenteric confluent and posterior segment of the right branch of the portal vein. These findings were suggestive of a lymphoproliferative disorder. Aspiration cytology of the adrenal mass and inguinal adenopathies was compatible with diffuse large B-cell lymphoma with areas of transformation to Burkitt’s lymphoma.
We describe a rare form of lymphoma, and a very unusual presentation of primary intraocular lymphoma with atypical symptoms.

LEARNING POINTS

KEYWORDS

Intraocular lymphoma, ocular haemorrhage, adrenal mass

INTRODUCTION

Intraocular lymphoma (IOL) is a life-threatening condition which results from one of two types of a rare lymphocytic malignancy: primary intraocular lymphoma (PIOL) and secondary intraocular lymphoma (SIOL) [1–3]. The former is mainly a subtype of primary central nervous system lymphoma (PCNSL) [1, 2, 4, 5]. It can arise in the retina, uvea, vitreous [5] or optic nerve [1, 6]. By far the most common PIOL is primary vitreoretinal lymphoma (PVRL). IOL can also originate from outside the central nervous system (CNS) by metastasizing to the eye. These tumours are known as SIOL. The most common subtype of SIOL is systemic diffuse large B-cell lymphoma (DLBCL). Most cases have a B-cell origin [1, 4, 5], but there are also T-cell variants, which are very rarer.
The incidence of IOL has increased in recent years [1, 4]. There appears to be no racial [1, 5] or gender predilection. The aetiology remains unknown. Diagnosis remains challenging and there is often misdiagnosis and delay [1, 5–7]. Therefore, it is important to keep in mind that ocular haematoma or subconjunctival bleeding may indicate intraocular disease.
Approximately one-third of PIOL patients have concurrent PCNSL at presentation and up to 92% will develop PCNSL within a mean of 8–29 months [5]. Tumour recurrence is common and sometimes treatment cannot prevent local recurrence and CNS involvement.

CASE DESCRIPTION

A 79-year-old man, with a medical history of atrial fibrillation for which he was taking warfarin, was admitted to hospital with a 3-month history of fever, night sweats, productive cough and significant weight loss, with no response to previous antibiotic regimens. He also referred the emergence of bilateral periorbital haematoma and subconjunctival haemorrhage associated with severe retro-orbital headache. There was no history of trauma or other reported symptoms.
Physical examination showed pale mucous membranes, bilateral peri-orbital haematoma, subconjunctival haemorrhage, and deep centrimetric cervical adenopathies with a hard consistency.
Laboratory investigation showed bicytopenia with normochromic normocytic anaemia and thrombocytopenia, an International Normalized Ratio above the therapeutic range (INR 5.57), increased sedimentation rate (120 mm in the 1st hour), raised lactate dehydrogenase level (1098 IU/l) and elevated beta-2-microglobulin (5.85 mg/l).
Infectious diseases were ruled out by serology studies, and blood and sputum bacterial and mycobacterial culture. Autoimmunity tests were negative.
To investigate the non-traumatic peri-orbital haematoma, subconjunctival haemorrhage and severe retro-orbital headache, brain and orbit computed tomography (CT) scans were performed and showed intra-conical intra-orbital lesions (Fig. 1a). A brain MRI indicated these lesions were highly suggestive of a lymphoproliferative disorder.
A body CT scan revealed cervical adenopathies, expansive lesions of the adrenal glands, and thrombosis of the splenomesenteric confluent and posterior segment of the right branch of the portal vein (Fig. 1b). Abdominal MRI was performed to clarify the CT findings but was inconclusive regarding the nature of the adrenal gland lesions. A positron emission tomography (PET) scan showed metabolically active disease at the bilateral intra-orbital, ganglionic, hepatic and bilateral adrenal levels (Fig. 2).

Figure 1 (click to enlarge)

Figure 2 (click to enlarge)

Figure 1. Full body CT scan showing cervical adenomegalies, expansive lesions in the adrenal glands, and thrombosis of the splenomesenteric arterynconfluent and posterior segment of the right branch of the portal vein
Figure 2 PET scan demonstrating metabolically active disease at the bilateral intra-orbital, ganglionic, hepatic and bilateral adrenal levels

DISCUSSION

The diagnosis of IOL requires a multidisciplinary approach. Although it has been reported that women are more commonly affected than men [3, 5, 8, 9] in their fifth to seventh decade of life, our patient was male and in his seventies.
Due to its rarity and ability to mimic other diseases [1, 3, 5], IOL requires a multidisciplinary approach involving traditional immunocytochemistry, morphological assessment and molecular analysis [5]. The differential diagnosis includes infections such as syphilis, tuberculosis, cytomegalovirus (CMV), HIV and toxoplasmosis, inflammatory diseases such as sarcoidosis, multiple sclerosis, pars planitis, other metastatic tumours, and idiopathic intermediate uveitis [3, 5, 10]. Consequently, our patient was extensively investigated.
The fever, night sweats, productive cough and significant weight loss suggested an infectious, inflammatory, autoimmune or neoplastic cause. Serology and autoimmune tests were negative. The brain CT scan indicated possible neoplastic disease so a brain MRI was performed to examine the intra-conical intra-orbital lesions and strongly suggested a lymphoproliferative disorder. MRI is more sensitive than CT for detecting lesions in the CNS, but both are limited for evaluating ophthalmic diseases [5]. The MRI indicated these lesions were highly suggestive of a lymphoproliferative disorder, so a body CT scan, an abdominal MRI and, lastly, a PET scan were performed. Histological identification is essential for diagnosis [1, 4, 11], so it was only after cytological examination that the diagnosis was made.
IOL prognosis remains poor and depends on whether the CNS is involved, the histopathological type and treatment opportunity. The mortality rate ranges between 9% and 81% [1, 5]. In our case, despite the absence bone marrow and CNS involvement, the patient had a poor performance status and refused curative chemotherapy.
Intraocular disease was not suspected at first in this patient. The first investigations considered infectious diseases such as atypical pneumonia due to Mycoplasma pneumoniae and Legionella pneumophilia, tuberculosis, syphilis, CMV, HIV and toxoplasmosis, inflammatory and autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus, and neoplastic diseases such as lymphoma, leukaemia and CNS tumours. Only with imaging test results and histological identification did the diagnostic hypothesis of intraocular disease arise. Like many other cases in the literature, the diagnosis was delayed for almost 3 months.
Although IOL is still very rare, its incidence has increased so it is important to recognize the risk factors and signs suggestive of intraocular disease, such as bleeding or periocular haematoma. This condition merits further investigation in order to improve outcomes.

References
  1. Chaput F, Amer R, Baglivo E, Touitou V, Kozyreff A, Bron, D, et al. Intraocular T-cell lymphoma: clinical presentation, diagnosis, treatment, and outcome. Ocul Immunol Inflamm 2017;25(5):644–653.
  2. Karakawa A, Taoka K, Kaburaki T, Tanaka R, Shinozaki-Ushiku A, Hayashi H, et al. Clinical features and outcomes of secondary intraocular lymphoma. Br J Haematol 2018;183(4):668–671.
  3. Touhami S, Audo I, Terrada C, Gaudric A, LeHoang P, Touitou V, et al. Neoplasia and intraocular inflammation: from masquerade syndromes to immunotherapy-induced uveitis. Prog Retin Eye Res 2019;72:100761.
  4. Batis V, Shuttleworth J, Shuttleworth G, Williams GS. Diagnostic dilemma of ocular lymphoma. BMJ Case Reports 2019;12(6):e229513.
  5. Sagoo MS, Mehta H, Swampillai AJ, Cohen VM, Amin SZ, Plowman PN, et al. Primary intraocular lymphoma.Surv Ophthalmol 2014;59(5):503–516.
  6. Reichstein D. Primary vitreoretinal lymphoma: an update on pathogenesis, diagnosis and treatment. Current Opin Ophthalmol 2016;27(3):177–184.
  7. Araujo I, Coupland SE. Primary vitreoretinal lymphoma—a review. Asia Pac J Ophthalmol 2017;6(3):283–289.
  8. Berenbom A, Davila RM, Lin HS, Harbour JW. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye 2007;21(9):1198–1201.
  9. Buettner H, Bolling JP. Intravitreal large-cell lymphoma. Mayo Clin Proc 1993;68(10):1011–1015.
  10. Dunn JP. Interleukins in the diagnosis of intraocular lymphoma: do we still need histologic confirmation? Retina 2018;38(4):647–649.
  11. Freedman K, Shenoy S. Mucosa-associated lymphoid tissue lymphoma with intraocular and orbital involvement: case presentation and review of the literature. Orbit 2018;37(4):243–247.